Gyre Therapeutics (GYRE) Tax Provisions (2009 - 2026)
Gyre Therapeutics (GYRE) recorded Tax Provisions of -$164,000 in Q2 2026, compared with $662,000 a year earlier.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Tax Provisions (2009 - 2026) Analysis & Trends
On a TTM basis, Gyre Therapeutics' Tax Provisions came in at $3.45 million as of Jun 30, 2026, up 21.5% year-over-year; for FY2025, it was $4.56 million, down 14.4% from FY2024.
- Annual Tax Provisions has a three-year compound annual growth rate of -3.7% (FY2022 to FY2025).
- Across earlier years, Tax Provisions came in at $5.32 million in FY2024 (-37.5%), $8.52 million in FY2023 (+67.0%) and $5.1 million in FY2022.
- The Q2 2026 figure is the lowest quarterly Tax Provisions in data going back to Q2 2010.
- On a year-over-year basis, Tax Provisions rose in two of the last seven quarters, with growth averaging 43.5%.
- Peak year-over-year performance for Tax Provisions in the last five years was growth of 540.4% in Q4 2025, against a decline of 86.3% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $621,000 (Q1 2026), $1.3 million (Q4 2025) and $1.69 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 1.96 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -176.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 609.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 492.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -842.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 822.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 634.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 134.00 Mn |
| 10 | Gyre Therapeutics | 487.81 Mn | 295.13 Mn | 30.99 Mn | 733,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 733,000.00 |
| Jun 30, 2026 | -164,000.00 |
| Mar 31, 2026 | 621,000.00 |
| Dec 31, 2025 | 2.40 Mn |
| Sep 30, 2025 | 593,000.00 |
| Jun 30, 2025 | 662,000.00 |
| Mar 31, 2025 | 901,000.00 |
| Dec 31, 2024 | 203,000.00 |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.50 Mn |
| Mar 31, 2024 | 2.55 Mn |
| Dec 31, 2023 | 699,000.00 |
| Sep 30, 2023 | 3.68 Mn |
| Jun 30, 2023 | 2.08 Mn |
| Mar 31, 2023 | 2.05 Mn |
| Dec 31, 2022 | 5.10 Mn |
| Mar 31, 2015 | 21,000.00 |
| Dec 31, 2014 | 16,000.00 |
| Sep 30, 2014 | 11,000.00 |
| Jun 30, 2014 | 45,000.00 |
API Access
Gyre Therapeutics Tax Provisions API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=tax-provisions&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "tax-provisions", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=tax-provisions&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();